| REGENERON PHARMAC.DL-,001 | 516.70 / +0.96% |
| Date/Time | 08/11 / 08:21 |
| Chg. / Chg.(%) | 4.90 / +0.96% |
| Bid | 512.40 / 10 |
| Ask | 517.80 / 10 |
| Open | 516.70 |
| Previous Close | 511.80 |
| High | 516.70 |
| Low | 516.70 |
| Volume [EUR] | 0.00 |
| Volume [Units] | 0 |
| Price fixings | 2 |
| ISIN | US75886F1075 |
| Security | RGO |
| Exchange | Düsseldorf |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| TradeGate | 514.900 |  |
55 |
| Frankfurt | 517.1000 |  |
53 |
| München | 521.00 |  |
5 |
| Hamburg | 515.50 | |
0 |
| Düsseldorf | 516.70 | |
0 |
| Berlin | 516.30 | |
0 |
| Vienna Globa.. | 519.70 | |
0 |
| gettex | 518.000 | |
|
| Lang & Schwa.. | 512.90 | |
|
| Stuttgart | 514.700 | |
|
| NASDAQ | 608.2400 | |
624,742 |
| Cboe US | 608.11 | 29,800 | |
| IEX | 608.11 | |
13,220 |
| London Inter.. | 600.48 | 783 | |
| Mexico | 13,932.28 | 62 | |
| SIX Swiss Ex.. | 304.89 |
News
- Regeneron's net income jumps 365% to $897M in Q2
08/05/2020 / 12:35 - TeleTrader - Regeneron falls over 4% ahead of lower drug prices expectations
07/24/2020 / 17:57 - TeleTrader - Regeneron gets $450M for vaccine advancement
07/07/2020 / 14:40 - TeleTrader - Regeneron to start Phase 3 virus treatment trials
07/06/2020 / 13:35 - TeleTrader - Regeneron starts clinical trial of COVID-19 treatment
06/11/2020 / 13:33 - TeleTrader
Real-time